Nirmidas Biotech provides innovative solutions to life science and healthcare problems and aims to improve the quality of human life. Nirmidas develops and manufactures breakthrough technologies in biological testing, assays, and imaging, based on a novel red to near-infrared fluorescence enhancing detection platform. We aim to develop personal and portable diagnostic systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening applications. Our products lie at the intersection of life science research, in vitro diagnosis, and digital healthcare.
Palo Alto, US
Size (employees)
10 (est)-9%
Nirmidas Biotech was founded in 2013 and is headquartered in Palo Alto, US
Report incorrect company information

Key People/Management at Nirmidas Biotech

Meijie Tang

Meijie Tang


Nirmidas Biotech Office Locations

Nirmidas Biotech has an office in Palo Alto
Palo Alto, US (HQ)
2627 Hanover St
Show all (1)
Report incorrect company information

Nirmidas Biotech Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$2 m

Latest funding size

$2 m

Time since last funding

4 years ago


Nirmidas Biotech's latest funding round in August 2014 was reported to be $2 m. In total, Nirmidas Biotech has raised $2 m
Report incorrect company information